1 ABSTRACT This invention relates to the field of cancer management, and in particular to the field of phytomedicine and nutraceutical composition for management of cancer, control of viral, bacterial and fungal infections, as well as other associated illnesses. This invention focuses on Solidago Canadensis and on its efficacy as anticancer agent, whereby 100% aqueous extract of Solidago Canadensis showed strong DNA groove binding property through DNA binding assays using CT DNA fragments. Additionally, the Solidago Canadensis plant has parallel role in anthelmintic, analgesic and anti-infective activities, as these ailments are usually associated with cancer. In summary, Solidago Canadensis plant demonstrated much more potent anticancer activities compared to the standard drugs, but without the negative side effects and can be administered alone or concomitantly for greater effect.
